Quick reminder for those of you on Twitter to join us for a live chat at 3 pm Eastern/Noon Pacific on the state of biotech startups. Carol Gallagher (@carol_gallagher) and Jason Rhodes (@JasonPaulRhodes) are the featured guests, who will field questions on how biotech startups can make it at a time when biotech venture capital is scarce.
You can follow the Q&A under the searchable hash tag #biostartups.
As always, you are welcome to add your comments or send questions directly to Jason, Carol, or anyone else joining the conversation. This should be a lively one. See you there online this afternoon.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
